Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

Biotechnology

Health Care

Health Data

Life Sciences

Mabylon AG

Mabylon AG's headquarters in Schlieren, Switzerland

Alcide Barberis

Tiziana Sonati

Niccolo Pengo

This department focuses on the discovery and characterization of antibodies and molecular biology research.

Research and Development

This department focuses on advancing research and development in antibody discovery and protein engineering.

Biotechnology Research

This department provides strategic direction and oversees the overall operations of the organization.

Executive Leadership

This department focuses on research and development in scientific disciplines, driving innovation and discovery.

Mabylon AG

Org chart

Teams

Research and Development

Biotechnology Research

Executive Leadership

Scientific Services

Offices

Mabylon AG

Org chart

Teams

Research and Development

Biotechnology Research

Executive Leadership

Scientific Services

Offices

Related companies